You have 9 free searches left this month | for more free features.

acalabrutinib

Showing 1 - 25 of 68

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acalabrutinib in Chronic Lymphocytic Leukaemia in United Kingdom

Not yet recruiting
  • Chronic Lymphocytic Leukemia, CLL
  • Acalabrutinib
  • (no location specified)
Sep 27, 2022

Mantle Cell Lymphoma Trial in Houston (Acalabrutinib)

Recruiting
  • Mantle Cell Lymphoma
  • Acalabrutinib
  • Houston, Texas
    M D Anderson Cancer Center
Aug 22, 2022

Chronic Lymphocytic Leukemia (CLL) Trial in Boston (Ibrutinib, Copanlisib, Acalabrutinib)

Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
May 13, 2022

CNS Lymphoma Trial in Chapel Hill, Winston-Salem (Acalabrutinib, Isavuconazole)

Recruiting
  • Central Nervous System Lymphoma
  • Chapel Hill, North Carolina
  • +1 more
Mar 24, 2022

Food Allergy, Food Allergy Peanut Trial in Baltimore (Acalabrutinib)

Recruiting
  • Food Allergy
  • Food Allergy Peanut
  • Acalabrutinib
  • Baltimore, Maryland
    Johns Hopkins Bayview Medical Center
Dec 30, 2021

Chronic Lymphocytic Leukemia, CLL/SLL Trial in New York (Acalabrutinib)

Withdrawn
  • Chronic Lymphocytic Leukemia
  • CLL/SLL
  • Acalabrutinib
  • New York, New York
    Weill Cornell Medicine
Mar 25, 2022

Post-transplant Lymphoproliferative Disorder Trial in Cleveland (Rituximab, Acalabrutinib, CT scans)

Recruiting
  • Post-transplant Lymphoproliferative Disorder
  • Cleveland, Ohio
    Cleveland Clinic, Case Comprehensive Cancer Center
Feb 2, 2022

Mantle Cell Lymphoma Trial (Acalabrutinib, Rituximab)

Not yet recruiting
  • Mantle Cell Lymphoma
  • (no location specified)
Aug 4, 2021

Mantle Cell Lymphoma Trial in Saint Louis (Bendamustine, Rituximab, Acalabrutinib)

Active, not recruiting
  • Mantle Cell Lymphoma
  • Saint Louis, Missouri
    Washington University School of Medicine
Feb 2, 2022

Primary CNS Lymphoma, Secondary CNS Lymphoma Trial in Saint Louis (Durvalumab, Acalabrutinib)

Recruiting
  • Primary Central Nervous System Lymphoma
  • Secondary Central Nervous System Lymphoma
  • Saint Louis, Missouri
    Washington University School of Medicine
Mar 14, 2022

Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) Trial in Rochester (Acalabrutinib, Rituximab)

Active, not recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • Small Lymphocytic Lymphoma (SLL)
  • Rochester, New York
    University of Rochester
Feb 7, 2022

Lymphoma, Mantle Cell Lymphoma Trial in Houston (Acalabrutinib, Rituximab, Brexucabtagene Autoleucel)

Not yet recruiting
  • Lymphoma
  • Mantle Cell Lymphoma
  • Acalabrutinib
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 10, 2022

Mantle Cell Lymphoma Trial in New York (Acalabrutinib, Lenalidomide, Rituximab)

Recruiting
  • Mantle Cell Lymphoma
  • Acalabrutinib
  • +2 more
  • New York, New York
    Weill Cornell Medicine
Oct 29, 2021

Autoimmune Hemolytic Anemia, Chronic Lymphocytic Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Trial in

Recruiting
  • Autoimmune Hemolytic Anemia
  • +3 more
  • Acalabrutinib
  • Duarte, California
    City of Hope Medical Center
Mar 9, 2022

COVID-19 Trial in Porto Alegre, Ribeirão Preto, Sao Paulo (Acalabrutinib)

Terminated
  • COVID-19
  • Acalabrutinib
  • Porto Alegre, Brazil
  • +3 more
Nov 16, 2021

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Houston (Acalabrutinib, Obinutuzumab)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Acalabrutinib
  • Obinutuzumab
  • Houston, Texas
    M D Anderson Cancer Center
Jul 14, 2022

Mantle Cell Lymphoma Trial in Canada (Acalabrutinib, R-CHOP chemo)

Recruiting
  • Mantle Cell Lymphoma
  • Acalabrutinib
  • R-CHOP chemotherapy
  • Vancouver, British Columbia, Canada
  • +3 more
Mar 17, 2022

Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia Trial in

Not yet recruiting
  • Recurrent Chronic Lymphocytic Leukemia
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
May 20, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Columbus (Acalabrutinib, Obinutuzumab, Venetoclax)

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Acalabrutinib
  • +2 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Apr 13, 2022

Healthy Volunteers Trial in Tempe (Acalabrutinib, Fluconazole, Isavuconazole)

Completed
  • Healthy Volunteers
  • Acalabrutinib
  • +2 more
  • Tempe, Arizona
    Celerion
Nov 17, 2021

Hepatic Impairment, Hepatic Insufficiency, Healthy Subjects Trial in Miami, Orlando, Knoxville (acalabrutinib)

Completed
  • Hepatic Impairment
  • +2 more
  • acalabrutinib
  • Miami, Florida
  • +2 more
Aug 16, 2021

Healthy Volunteers Trial in Madison (Acalabrutinib, Microtracer [14C]ACP-196)

Completed
  • Healthy Volunteers
  • Acalabrutinib
  • Microtracer [14C]ACP-196
  • Madison, Wisconsin
    Covance Clinical Research Unit, Inc.
May 21, 2021

Healthy Volunteers Trial in Tempe (Acalabrutinib, SmartPill®)

Completed
  • Healthy Volunteers
  • Tempe, Arizona
    Celerion
Jun 2, 2021

Recurrent Follicular Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Nodal Marginal Zone Lymphoma Trial (Acalabrutinib,

Withdrawn
  • Recurrent Follicular Lymphoma
  • +8 more
  • (no location specified)
Jun 2, 2022

Mantle Cell Lymphoma Trial in Duarte (Acalabrutinib, Ublituximab, Umbralisib)

Suspended
  • Mantle Cell Lymphoma
  • Acalabrutinib
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Jun 7, 2022